Contact Us Global Investors & Media ❯ Featured Coverage Click Below to Sort Topics ALL IN THE NEWS OUR PEOPLE PATIENT ADVOCACY INNOVATION JOHN CROWLEY John F. Crowley Featured on CNBC John Crowley discuss clinical trial results for Pompe disease. See clip here Tags: In The News John Crowley Bradley Campbell Interviewed for Site Selection Magazine Bradley Campbell, President and COO of Amicus Therapeutics, was recently interviewed for Site Selection Magazine, sharing insight on the Company’s strategic decision to select emerging medical hub, Philadelphia, as choice city and new home of Amicus’ state-of-the-art Global Research and Gene Therapy Center of Excellence. View Article Tags: In The News Our People Innovation Pharmaceutical Executive Highlights Culture & Compliance at Amicus In an article in Pharmaceutical Executive, Patrik Florencio, Chief Compliance and Risk Officer, and John F. Crowley, Chairman and CEO, shared the concrete action steps Amicus has taken to ensure it acts with integrity and responsibility by building and sustaining a culture of business ethics. View Article Tags: In The News Our People John Crowley Featured Guest on The Tim Ferriss Show Podcast Amicus Chairman and CEO, John Crowley, sat down with renowned podcast host, Tim Ferriss of The Tim Ferriss Show, to talk life, being a father of two children living with Pompe disease, and leading a rare disease biotechnology company towards the forefront of the human genome medicine revolution. Listen to the podcast Tags: Our People John Crowley The Healthcare Technology Report Names John Crowley Top Biotech CEO of 2020 John Crowley was awarded the Healthcare Technology Report #1 ranking of the Top 25 Biotech CEOs of 2020 for his career accomplishments and demonstrated leadership capabilities over a sustained period of time. “We paid particular attention to CEOs who dedicated themselves to developing deep domain expertise, running organizations of high integrity, and who were mission-driven in solving critical health problems.” – The Healthcare Technology Report View the Full Article Tags: In The News Our People John Crowley Amicus Wins Top Prize at UK Prix Galien Awards Amicus Therapeutics wins the UK Prix Galien award for Innovative Product, marking the first time in the history of the awards that an orphan drug received this esteemed recognition. View Article Tags: In The News Innovation Amicus CEO on a Mission to Cure Pompe and Help His Two Children John Crowley, Chairman and CEO of Amicus Therapeutics, was interviewed by Pompe Disease News sharing his personal experience with Pompe disease, Enzyme Replacement Therapy (ERT), and the optimistic future for the next-generation of ERT and gene therapy. View Article Tags: John Crowley Amicus Chairman & CEO John F. Crowley Featured on Entrepreneur Weekly Podcast Amicus Chairman and CEO John Crowley sits down with Entrepreneur Weekly’s Alan Taylor to discuss his personal story with Pompe disease and how he is spearheading an entrepreneurial culture within the biotech industry. Listen Here Tags: In The News John Crowley Amicus-UPenn Partnership Named ‘Deal Of The Year’ By Penn Center For Innovation Amicus Therapeutics and Dr. James Wilson with the UPenn Gene Therapy Program are awarded Deal of the Year for their collaboration to advance AAV gene therapy research for rare metabolic disorders. View Article Tags: Innovation Amicus Expands to Emerging Philadelphia Gene Therapy Hub Amicus Therapeutics featured across media outlets for establishing their presence in Philadelphia’s uCity Square. Media Coverage Includes: The Philadelphia Inquirer: View Article Philadelphia Business Journal: View Article FierceBiotech: View Article View Article Tags: In The News Innovation Jayne Gershkowitz Featured on PharmaVOICE Woman of the Week (WoW) Podcast Jayne Gershkowitz, Chief Patient Advocate at Amicus Therapeutics, is a passionate advocate and expert in a wide variety of issues affecting individuals with rare diseases and their families. She has more than 18 years of experience of strategic marketing, resource development and executive management in nonprofit healthcare and the rare disease patient community. In the podcast she shares her experiences and perspectives on the impact of patient advocacy for patients and families living with rare diseases. Listen to the Podcast Tags: In The News Our People Patient Advocacy Amicus Co-Sponsor of Global Genes “RARE Webinar – Precision Medicine” For the full webinar Listen Here. PP-GA-ALL-0004-8019 Listen Here Tags: In The News Patient Advocacy Globes Profiles John C. Crowley, Chairman and CEO Globes, the leading financial newspaper in Israel, profiles John Crowley’s personal story and Amicus Therapeutics View Article Tags: Our People John Crowley NP-NN-ALL-00050720 About Amicus Chairman’s Welcome Leadership Belief Statement Contact Us Message from BIO Patient Advocacy Disease Information Rare Stories Patient Advisory Boards Corporate Giving Resources Expanded Access Programs & Pipeline Pipeline Our Programs Clinical Trials Product Overview Amicus Assist™ Responsibility Ethics & Compliance Global Medical Affairs Corporate Giving Healing Beyond Disease ESG Report Investors & Media Corporate Governance Press Releases Events & Presentations Annual Reports & Proxies SEC Filings Stock Performance Investor FAQs Featured Coverage Careers Overview Who We Are Search Social Media Twitter YouTube LinkedIn Copyright © 2021 Amicus Therapeutics, Inc. All rights reserved. NP-AT-ALL-00011119 Cookies Statement Terms of Use Privacy Notice Amicus Therapeutics informs you that our website uses its own and third party cookies to improve our services and collect statistical information about your browsing. By clicking accept, we consider that you accept its use. For more information, or to know how to change the configuration, consult our Privacy Policy. Accept